Company News, Patents

Fuji Chemical Granted Inflammation Patent

Patent No. US 7,078,040 B2: Fuji Chemical Industry Co., Ltd., Mount Laurel, NJ has been granted a patent for inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxanthin. Fuji’s pending patents for astaxanthin include the areas of eye fatigue, wrinkle reduction, weight loss, diabetic nephropathy and dyspepsia.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters